After several months of negotiation, Congress reached a compromise on the terms for additional COVID-19 relief shortly before the end of the year. The bill, known as the Response and Relief Act, provides over $900 billion of stimulus to individuals, corporations, and governments.
Despite being similar to the CARES Act in terms of its scope, the bill is substantially smaller. However, the economy is in a much different place today than it was in when the CARES Act was passed. After hitting a trough in March and April, the economy has experienced an unprecedented economic recovery, with GDP growing more than 33% in the third quarter and jobless claims falling to a fraction of their initial levels. While economic activity certainly remains well below its pre-pandemic levels, the economy is clearly in a much better place.
Furthermore, with several effective vaccines now being distributed, we may be starting to see a path back toward normalcy. Of course, it appears likely to take at least several months before the vaccines are widely available and appropriately administered. In the meantime, the recently passed bill should help to bridge the economic gap that has been created from the response to the virus, with more likely on the horizon. The outcome of the Georgia Senate runoff elections established a Democrat majority by the narrowest of margins, which increases the likelihood of another sizable package. The bottom line? The shot in the arm, from both the vaccine and fiscal stimulus, creates an optimistic backdrop for economic growth in 2021.
Past performance does not guarantee future results. All investments include risk and have the potential for loss as well as gain.
Data sources for peer group comparisons, returns, and standard statistical data are provided by the sources referenced and are based on data obtained from recognized statistical services or other sources believed to be reliable. However, some or all of the information has not been verified prior to the analysis, and we do not make any representations as to its accuracy or completeness. Any analysis nonfactual in nature constitutes only current opinions, which are subject to change. Benchmarks or indices are included for information purposes only to reflect the current market environment; no index is a directly tradable investment. There may be instances when consultant opinions regarding any fundamental or quantitative analysis may not agree.
Plante Moran Financial Advisors (PMFA) publishes this update to convey general information about market conditions and not for the purpose of providing investment advice. Investment in any of the companies or sectors mentioned herein may not be appropriate for you. You should consult a representative from PMFA for investment advice regarding your own situation.